| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |